T-101
治疗用乙型肝炎腺病毒
Report date: 2025/03/18 17:01:53
Base Information
Drug NameT-101
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[4]
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesTransgene Sa
China Registration ClassClass 1 therapeutic biologic in China
Develop Information
Active CompaniesTasly Chuangshijie (Tianjin) Biopharmaceutical Co Ltd
Inactive CompaniesTransgene Sa
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A